Pacific Biosciences of California (PACB) Earnings Date, Estimates & Call Transcripts → A new way to collect income from stocks (From DTI) (Ad) Free pacb Stock Alerts $1.38 +0.02 (+1.47%) (As of 04/25/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 9After Market ClosesConfirmedActual EPS (Feb. 15) -$0.27 Beat By $0.02 Consensus EPS (Feb. 15) -$0.29 Read Call TranscriptListen to Call Get Pacific Biosciences of California Earnings AlertsEnter your email address below to receive the latest news and earnings results for PACB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePACB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PACB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Pacific Biosciences of California Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.29)($0.29)($0.29) Q3 20241($0.26)($0.26)($0.26) Q4 20241($0.26)($0.26)($0.26) 20243($0.81)($0.81)($0.81) Q1 20251($0.23)($0.23)($0.23) Q2 20251($0.22)($0.22)($0.22) PACB Earnings Date and InformationPacific Biosciences of California last posted its earnings results on February 15th, 2024. The biotechnology company reported ($0.27) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.02. The firm earned $58.36 million during the quarter, compared to analysts' expectations of $57.96 million. Its revenue for the quarter was up 113.3% on a year-over-year basis. Pacific Biosciences of California has generated ($1.21) earnings per share over the last year (($1.21) diluted earnings per share). Earnings for Pacific Biosciences of California are expected to grow in the coming year, from ($1.00) to ($0.84) per share. Pacific Biosciences of California has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. Pacific Biosciences of California will be holding an earnings conference call on Thursday, May 9th at 5:00 PM Eastern. Interested parties can register for or listen to the call.. Read More Pacific Biosciences of California Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Confirmed)------- 2/15/2024Q4 2023($0.29)($0.27)+$0.02($0.23)$57.96 million$58.36 million 10/30/2023Q3 2023($0.29)($0.27)+$0.02($0.28)$48.76 million$55.70 million 8/2/2023Q2 2023($0.32)($0.26)+$0.06($0.24)$40.12 million$47.57 million 5/2/2023Q1 2023($0.33)($0.31)+$0.02($0.26)$34.38 million$38.90 million 2/16/2023Q4 2022($0.34)($0.35)($0.01)($0.33)$27.29 million$27.35 million 11/7/2022Q3 2022($0.35)($0.32)+$0.03($0.30)$35.30 million$32.31 million Get the Latest News and Ratings for PACB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacific Biosciences of California and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022($0.34)($0.34)-($0.36)$35.54 million$35.47 million 5/4/2022Q1 2022($0.32)($0.37)($0.05)($0.37)$32.82 million$33.17 million 2/15/2022Q4 2021($0.28)($0.30)($0.02)($0.29)$36.00 million$36.02 million 11/2/2021Q3 2021($0.22)($0.23)($0.01)($0.54)$32.93 million$34.89 million 8/2/2021Q2 2021($0.21)($0.21)-($0.21)$30.46 million$30.61 million 4/29/2021Q1 2021($0.45)($0.18)+$0.27$0.09$25.66 million$29.00 million Pacific Biosciences of California Earnings - Frequently Asked Questions When is Pacific Biosciences of California's earnings date? Pacific Biosciences of California has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on PACB's earnings history. Did Pacific Biosciences of California beat their earnings estimates last quarter? In the previous quarter, Pacific Biosciences of California (NASDAQ:PACB) reported ($0.27) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.29) by $0.02. Learn more on analysts' earnings estimate vs. PACB's actual earnings. How can I listen to Pacific Biosciences of California's earnings conference call? The conference call for Pacific Biosciences of California's latest earnings report can be listened to online. Listen to Conference Call How can I read Pacific Biosciences of California's conference call transcript? The conference call transcript for Pacific Biosciences of California's latest earnings report can be read online. Read Transcript How much revenue does Pacific Biosciences of California generate each year? Pacific Biosciences of California (NASDAQ:PACB) has a recorded annual revenue of $200.52 million. How much profit does Pacific Biosciences of California generate each year? Pacific Biosciences of California (NASDAQ:PACB) has a recorded net income of -$306.73 million. PACB has generated -$1.21 earnings per share over the last four quarters. What is Pacific Biosciences of California's EPS forecast for next year? Pacific Biosciences of California's earnings are expected to grow from ($1.00) per share to ($0.84) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Nautilus Biotechnology Earnings Results Akoya Biosciences Earnings Results Harvard Bioscience Earnings Results Quanterix Earnings Results Seer Earnings Results Bionano Genomics Earnings Results Accelerate Diagnostics Earnings Results Cytek Biosciences Earnings Results Standard BioTools Earnings Results EyePoint Pharmaceuticals Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:PACB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
